ANDA 83827, held by Alra. Imipramine Hydrochloride.
As of Nov 16, 2026, ANDA 83827 (Pramine), held by Alra, was first approved by FDA on Jun 19, 1978, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 19, 1978 | Original application | Approved |
| Pramine10MG · tablet;oral | Imipramine Hydrochloride | Discontinued |
| Pramine25MG · tablet;oral | Imipramine Hydrochloride | Discontinued |
| Pramine50MG · tablet;oral | Imipramine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters